BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8818443)

  • 1. Hemoptysis and unilateral intra-alveolar hemorrhage complicating intravenous thrombolysis for myocardial infarction.
    Hammoudeh AJ; Haft JI; Eichman GT
    Clin Cardiol; 1996 Jul; 19(7):595-6. PubMed ID: 8818443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary hemorrhage and acute respiratory failure secondary to thrombolytic treatment with tissue plasminogen activator (rt-PA) in patients with acute myocardial infarction].
    Sandar Núñez D; Ruiz Santana S; García Jiménez A; Castro Mao M
    Med Clin (Barc); 1997 Mar; 108(8):318. PubMed ID: 9121219
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of mortality and morbidity during four years after late thrombolysis in acute myocardial infarct.
    Liguori A; DiGregorio F; Napoli C
    Heart; 1996 Sep; 76(3):291. PubMed ID: 8868993
    [No Abstract]   [Full Text] [Related]  

  • 4. Diffuse alveolar hemorrhage following thrombolytic therapy for acute myocardial infarction.
    Yigla M; Sprecher E; Azzam Z; Guralnik L; Kapeliovich M; Krivoy N
    Respiration; 2000; 67(4):445-8. PubMed ID: 10940802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful intracoronary thrombolysis in cocaine-associated acute myocardial infarction.
    Yao SS; Spindola-Franco H; Menegus M; Greenberg M; Goldberger M; Shirani J
    Cathet Cardiovasc Diagn; 1997 Nov; 42(3):294-7. PubMed ID: 9367107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis utilisation in acute myocardial infarction in Bahrain.
    Chawla AK; Nambiar CA; Murad AA
    Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated doses of tissue plasminogen activator for failed thrombolysis: case report and review of the literature.
    Dakik HA; Nasrallah A
    Heart Dis; 2001; 3(6):362-4. PubMed ID: 11975820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 9. Diffuse pulmonary hemorrhage complicating thrombolytic therapy for acute myocardial infarction.
    Gopalakrishnan D; Tioran T; Emanuel C; Clark VL
    Clin Cardiol; 1997 Mar; 20(3):298-300. PubMed ID: 9068920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary thrombolysis in patients with acute myocardial infarction].
    Kambara H; Fudo T; Ono S
    Kokyu To Junkan; 1992 Jun; 40(6):537-47. PubMed ID: 1620990
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolytic therapy for myocardial infarction.
    Brophy J
    N Engl J Med; 1998 Feb; 338(8):545-6; author reply 546-7. PubMed ID: 9471557
    [No Abstract]   [Full Text] [Related]  

  • 12. Pitfalls of thrombolytic therapy for myocardial infarction.
    Ceola WM; Harik SI
    J Ark Med Soc; 1998 Jul; 95(2):73-4. PubMed ID: 9676061
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolytic therapy for myocardial infarction.
    Frei S
    N Engl J Med; 1998 Feb; 338(8):545; author reply 546-7. PubMed ID: 9471556
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thrombolytic therapy of ischemic heart disease].
    Kanmatsuse K; Nagao K; Kikushima K; Shioiri K
    Nihon Naika Gakkai Zasshi; 1997 Sep; 86(9):1625-8. PubMed ID: 9410972
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemorrhagic ocular complications associated with the use of systemic thrombolytic agents.
    Chorich LJ; Derick RJ; Chambers RB; Cahill KV; Quartetti EJ; Fry JA; Bush CA
    Ophthalmology; 1998 Mar; 105(3):428-31. PubMed ID: 9499772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of acute myocardial infarction by thrombolytic therapy in a patient with primary antiphospholipid antibody syndrome.
    Ho YL; Chen MF; Wu CC; Chen WJ; Lee YT
    Cardiology; 1996; 87(4):354-7. PubMed ID: 8793173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Refibrinolysis with r-tPA for thrombosis of the mitral prosthesis after an acute myocardial infarct].
    Moreno R; San Román D; Ortega A; López de Sá E; Rey JR; García Fernández MA; López-Sendón JL; Delcán JL
    Rev Esp Cardiol; 1997 Nov; 50(11):812-4. PubMed ID: 9424707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
    Czyrski J
    Wiad Lek; 1989 Apr; 42(7):450-2. PubMed ID: 2516932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.